Evaluation of the benefit of the Health care reimbursement for the new generation of NSAIDs（COX-2 selective NSAIDs） via retrospective analysis using data warehouse of BNHI Taiwan.
碩士 === 長庚大學 === 醫務管理學研究所 === 95 === A new-generation non-steroid anti-inflammatory agent, known as COX-2, was introduced in 1998. This agent, according to clinical studies, produces a lower level of gastrointestinal toxicity than most conventional therapies and has soon become a popular treatment in...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2007
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/24730536060056057305 |